sexta-feira, 3 de outubro de 2008

Doctor's Guide, October, 03

Candesartan Increases Regression of Retinopathy in Type 2 Diabetes, Reduces Incidence in Type 1 Diabetes
NEW YORK -- September 25, 2008 -- Treatment with candesartan can increase regression of retinopathy in type 2 diabetes and reduce incidence of retinopathy in type 1 diabetes, according to the results of 2 studies, published early online and in an upcoming edition of The Lancet. In the first of the 2 articles, Nish Chaturvedi, National ...Full Story





Most read General Medicine news in the past 7 days

Papers and articles, pertaining to General Medicine, most read by your colleagues in the past 7 days

More news...

Nenhum comentário: